<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font5" size="7" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font7" size="7" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font8" size="10" family="SymbolMT" color="#000000"/>
	<fontspec id="font9" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font11" size="8" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font12" size="6" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font13" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font14" size="8" family="SymbolMT" color="#000000"/>
<text top="41" left="55" width="121" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Immunity &amp; Ageing 2006, 3 :10<i>Immunity &amp; Ageing</i></text>
<text top="41" left="368" width="186" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.immunityageing.com/content/3/1/10</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="108" segment_no="15" tag_type="text">Page 4 of 8<b>3</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="109" segment_no="16" tag_type="text">(page number not for citation purposes)</text>
<text top="204" left="55" width="242" height="9" font="font4" id="p1_t5" reading_order_no="20" segment_no="5" tag_type="title">The effect of age on CD56 dim NK cell number: cell number</text>
<text top="216" left="55" width="109" height="9" font="font4" id="p1_t6" reading_order_no="21" segment_no="5" tag_type="title">remains constant with age</text>
<text top="227" left="55" width="241" height="10" font="font6" id="p1_t7" reading_order_no="22" segment_no="7" tag_type="text">The influence of age on peripheral blood CD56 dim NK<i>(page number not for citation purposes)</i></text>
<text top="239" left="55" width="241" height="9" font="font6" id="p1_t8" reading_order_no="23" segment_no="7" tag_type="text">cells revealed relatively consistent numbers at all ages. A<i><b>The effect of age on CD56</b></i></text>
<text top="248" left="55" width="241" height="12" font="font6" id="p1_t9" reading_order_no="24" segment_no="7" tag_type="text">trend towards a slight increase in CD56 dim NK cells µ l/<i><b>dim </b></i></text>
<text top="263" left="55" width="241" height="9" font="font6" id="p1_t10" reading_order_no="25" segment_no="7" tag_type="text">blood was found between the 40–60 and 60+ year cohorts<i><b>NK cell number: cell number </b></i></text>
<text top="275" left="55" width="241" height="9" font="font6" id="p1_t11" reading_order_no="26" segment_no="7" tag_type="text">although this did not reach statistical significance (figure<i><b>remains constant with age</b></i></text>
<text top="286" left="55" width="241" height="9" font="font6" id="p1_t12" reading_order_no="27" segment_no="7" tag_type="text">3). A non-significant increase in CD56 dim NK cells as a</text>
<text top="298" left="55" width="241" height="9" font="font6" id="p1_t13" reading_order_no="28" segment_no="7" tag_type="text">percentage of the peripheral blood lymphoid pool was</text>
<text top="310" left="55" width="222" height="9" font="font6" id="p1_t14" reading_order_no="29" segment_no="7" tag_type="text">also observed with advancing age (table 2 , figure 4).</text>
<text top="334" left="55" width="53" height="10" font="font9" id="p1_t15" reading_order_no="30" segment_no="9" tag_type="title">Discussion</text>
<text top="345" left="55" width="241" height="9" font="font6" id="p1_t16" reading_order_no="31" segment_no="10" tag_type="text">The decline in immune function with increasing age is</text>
<text top="357" left="55" width="241" height="9" font="font6" id="p1_t17" reading_order_no="32" segment_no="10" tag_type="text">termed immune senescence and leads to impaired</text>
<text top="369" left="55" width="241" height="9" font="font6" id="p1_t18" reading_order_no="33" segment_no="10" tag_type="text">responses to vaccination, an increased incidence of</text>
<text top="380" left="55" width="241" height="9" font="font6" id="p1_t19" reading_order_no="34" segment_no="10" tag_type="text">autoimmune disorders and increased morbidity and mor-</text>
<text top="392" left="55" width="241" height="9" font="font6" id="p1_t20" reading_order_no="35" segment_no="10" tag_type="text">tality to infectious disease [12-15]. Immune senescence</text>
<text top="404" left="55" width="241" height="9" font="font6" id="p1_t21" reading_order_no="36" segment_no="10" tag_type="text">has been attributed to a number of factors including</text>
<text top="416" left="55" width="241" height="9" font="font6" id="p1_t22" reading_order_no="37" segment_no="10" tag_type="text">thymic involution and memory T cell accumulation</text>
<text top="427" left="55" width="241" height="9" font="font6" id="p1_t23" reading_order_no="38" segment_no="10" tag_type="text">resulting in contraction of the T cell repertoire. More<a href="">3). A n</a>on-significant increase in CD56</text>
<text top="439" left="55" width="241" height="9" font="font6" id="p1_t24" reading_order_no="39" segment_no="10" tag_type="text">recently, debate has focused on the role of innate cellular</text>
<text top="451" left="55" width="241" height="9" font="font6" id="p1_t25" reading_order_no="40" segment_no="10" tag_type="text">immunity with regard to impaired immune function.</text>
<text top="463" left="55" width="241" height="9" font="font6" id="p1_t26" reading_order_no="41" segment_no="10" tag_type="text">Remarque et al . have reported that elderly individuals</text>
<text top="474" left="55" width="241" height="9" font="font6" id="p1_t27" reading_order_no="42" segment_no="10" tag_type="text">with low NK numbers have a three-fold increased risk of<a href=""> (table 2 , fig</a>ure <a href="">4).</a></text>
<text top="486" left="55" width="241" height="9" font="font6" id="p1_t28" reading_order_no="43" segment_no="10" tag_type="text">mortality in the first two years of follow up compared to<b>Discussion</b></text>
<text top="498" left="55" width="241" height="9" font="font6" id="p1_t29" reading_order_no="44" segment_no="10" tag_type="text">those with high NK cells [16]. Functional studies have</text>
<text top="510" left="55" width="241" height="9" font="font6" id="p1_t30" reading_order_no="45" segment_no="10" tag_type="text">measured NK cell activity against the K562 tumour cell</text>
<text top="521" left="55" width="241" height="9" font="font6" id="p1_t31" reading_order_no="46" segment_no="10" tag_type="text">line and demonstrate impaired NK cell cytotoxicity in eld-</text>
<text top="533" left="55" width="241" height="9" font="font6" id="p1_t32" reading_order_no="47" segment_no="10" tag_type="text">erly donors [17]. Further evidence is derived from studies</text>
<text top="545" left="55" width="241" height="9" font="font6" id="p1_t33" reading_order_no="48" segment_no="10" tag_type="text">on centenarians, regarded as a model example of healthy<a href="">us disease [12-15]. Imm</a>une senescence</text>
<text top="557" left="55" width="241" height="9" font="font6" id="p1_t34" reading_order_no="49" segment_no="10" tag_type="text">ageing, who have been reported to have well preserved NK</text>
<text top="568" left="55" width="241" height="9" font="font6" id="p1_t35" reading_order_no="50" segment_no="10" tag_type="text">cell cytotoxicity [18]. Our data shows that NK cell num-</text>
<text top="204" left="313" width="241" height="9" font="font6" id="p1_t36" reading_order_no="51" segment_no="6" tag_type="text">bers are relatively stable with advancing age but as the</text>
<text top="216" left="313" width="241" height="9" font="font6" id="p1_t37" reading_order_no="52" segment_no="6" tag_type="text">total peripheral blood lymphocyte count decreases there</text>
<text top="228" left="313" width="241" height="9" font="font6" id="p1_t38" reading_order_no="53" segment_no="6" tag_type="text">is a small increase in the proportion of the lymphoid com-</text>
<text top="239" left="313" width="132" height="9" font="font6" id="p1_t39" reading_order_no="54" segment_no="6" tag_type="text">partment occupied by NK cells.</text>
<text top="262" left="313" width="241" height="10" font="font6" id="p1_t40" reading_order_no="55" segment_no="8" tag_type="text">Our findings demonstrate that the number of CD56 bright<i>et al</i></text>
<text top="275" left="313" width="241" height="9" font="font6" id="p1_t41" reading_order_no="56" segment_no="8" tag_type="text">NK cells declines with advancing age which may have con-</text>
<text top="286" left="313" width="241" height="9" font="font6" id="p1_t42" reading_order_no="57" segment_no="8" tag_type="text">siderable implications for NK cell function in the elderly</text>
<text top="298" left="313" width="241" height="9" font="font6" id="p1_t43" reading_order_no="58" segment_no="8" tag_type="text">cohort. This decline was apparent across all three age</text>
<text top="310" left="313" width="241" height="9" font="font6" id="p1_t44" reading_order_no="59" segment_no="8" tag_type="text">groups indicating a gradual decline with healthy ageing.<a href="">gh NK cells [16</a>]. Functional studies have</text>
<text top="321" left="313" width="241" height="10" font="font6" id="p1_t45" reading_order_no="60" segment_no="8" tag_type="text">The CD56 dim NK cell subset remains relatively constant</text>
<text top="333" left="313" width="241" height="9" font="font6" id="p1_t46" reading_order_no="61" segment_no="8" tag_type="text">but occupies a greater portion of the peripheral blood</text>
<text top="345" left="313" width="241" height="9" font="font6" id="p1_t47" reading_order_no="62" segment_no="8" tag_type="text">lymphoid pool with advancing age. Our findings are in<a href="">17]</a>. Further evidence is derived from studies</text>
<text top="357" left="313" width="241" height="9" font="font6" id="p1_t48" reading_order_no="63" segment_no="8" tag_type="text">keeping with Krishnaraj (1997) who also reports a signif-</text>
<text top="368" left="313" width="241" height="10" font="font6" id="p1_t49" reading_order_no="64" segment_no="8" tag_type="text">icant reduction in the proportion of CD56 bright cells with</text>
<text top="380" left="313" width="241" height="9" font="font6" id="p1_t50" reading_order_no="65" segment_no="8" tag_type="text">relative sparing of the CD56 dim subset [19]. This contrasts<a href="">18]</a>. Our data shows that NK cell num-</text>
<text top="392" left="313" width="241" height="9" font="font6" id="p1_t51" reading_order_no="66" segment_no="8" tag_type="text">with Borrego et al . (1999) who reports an expansion in the</text>
<text top="403" left="313" width="241" height="10" font="font6" id="p1_t52" reading_order_no="67" segment_no="8" tag_type="text">proportion in CD56 dim cells but little change in CD56 bright</text>
<text top="416" left="313" width="241" height="9" font="font6" id="p1_t53" reading_order_no="68" segment_no="8" tag_type="text">NK cells [20]. Differences in the methodology employed</text>
<text top="427" left="313" width="241" height="9" font="font6" id="p1_t54" reading_order_no="69" segment_no="8" tag_type="text">in these studies are likely to account for the variation in</text>
<text top="439" left="313" width="30" height="9" font="font6" id="p1_t55" reading_order_no="70" segment_no="8" tag_type="text">results.</text>
<text top="463" left="313" width="241" height="9" font="font6" id="p1_t56" reading_order_no="71" segment_no="11" tag_type="text">NK cell associated cytotoxic function is thought to be</text>
<text top="474" left="313" width="242" height="9" font="font6" id="p1_t57" reading_order_no="72" segment_no="11" tag_type="text">mediated primarily through the CD56 dim NK cell subset</text>
<text top="486" left="313" width="241" height="9" font="font6" id="p1_t58" reading_order_no="73" segment_no="11" tag_type="text">whereas the CD56 bright NK cells can be thought of prima-</text>
<text top="497" left="313" width="241" height="10" font="font6" id="p1_t59" reading_order_no="74" segment_no="11" tag_type="text">rily as a cytokine producing subset. The CD56 dim cell is</text>
<text top="509" left="313" width="241" height="10" font="font6" id="p1_t60" reading_order_no="75" segment_no="11" tag_type="text">more cytotoxic than the CD56 bright NK cell subset [21] and</text>
<text top="521" left="313" width="241" height="9" font="font6" id="p1_t61" reading_order_no="76" segment_no="11" tag_type="text">the morphological appearance of CD56 dim cells shows</text>
<text top="533" left="313" width="241" height="9" font="font6" id="p1_t62" reading_order_no="77" segment_no="11" tag_type="text">greater granularity [1]. A substantial body of data indi-</text>
<text top="544" left="313" width="241" height="10" font="font6" id="p1_t63" reading_order_no="78" segment_no="11" tag_type="text">cates that the CD56 bright subpopulation plays a critical role</text>
<text top="556" left="313" width="241" height="10" font="font6" id="p1_t64" reading_order_no="79" segment_no="11" tag_type="text">in the early innate immune response. CD56 bright NK cells</text>
<text top="568" left="313" width="241" height="9" font="font6" id="p1_t65" reading_order_no="80" segment_no="11" tag_type="text">have a higher proliferative capacity than CD56 dim NK cells</text>
<text top="595" left="55" width="228" height="7" font="font11" id="p1_t66" reading_order_no="81" segment_no="12" tag_type="title">Table 2: The effect of age on CD56 bright and CD56 dim NK cells</text>
<text top="613" left="59" width="15" height="7" font="font11" id="p1_t67" reading_order_no="82" segment_no="13" tag_type="table">Age</text>
<text top="613" left="283" width="22" height="7" font="font11" id="p1_t68" reading_order_no="83" segment_no="13" tag_type="table">20–40</text>
<text top="613" left="372" width="22" height="7" font="font11" id="p1_t69" reading_order_no="84" segment_no="13" tag_type="table">40–60</text>
<text top="613" left="466" width="14" height="7" font="font11" id="p1_t70" reading_order_no="85" segment_no="13" tag_type="table">60+</text>
<text top="635" left="59" width="14" height="7" font="font11" id="p1_t71" reading_order_no="86" segment_no="13" tag_type="table">N =</text>
<text top="635" left="283" width="8" height="7" font="font13" id="p1_t72" reading_order_no="87" segment_no="13" tag_type="table">25<a href=""> [19]. Th</a>is contrasts</text>
<text top="635" left="372" width="8" height="7" font="font13" id="p1_t73" reading_order_no="88" segment_no="13" tag_type="table">23</text>
<text top="635" left="466" width="8" height="7" font="font13" id="p1_t74" reading_order_no="89" segment_no="13" tag_type="table">67<i>et al</i></text>
<text top="643" left="59" width="104" height="10" font="font11" id="p1_t75" reading_order_no="90" segment_no="13" tag_type="table">CD56 bright µ l/blood (+/- SD)</text>
<text top="645" left="283" width="50" height="7" font="font13" id="p1_t76" reading_order_no="91" segment_no="13" tag_type="table">15.64 (+/-12.8)</text>
<text top="645" left="372" width="57" height="7" font="font13" id="p1_t77" reading_order_no="92" segment_no="13" tag_type="table">12.81 (+/-12) ***</text>
<text top="645" left="466" width="55" height="7" font="font13" id="p1_t78" reading_order_no="93" segment_no="13" tag_type="table">8.13 (+/-7.9)****</text>
<text top="655" left="59" width="147" height="8" font="font11" id="p1_t79" reading_order_no="94" segment_no="13" tag_type="table">CD56 bright as % of lymphocytes (+/-SD)</text>
<text top="656" left="283" width="42" height="7" font="font13" id="p1_t80" reading_order_no="95" segment_no="13" tag_type="table">0.76 (+/-0.6)<a href="">s [20]. D</a>ifferences in the methodology employed</text>
<text top="656" left="372" width="47" height="7" font="font13" id="p1_t81" reading_order_no="96" segment_no="13" tag_type="table">0.72 (+/-0.6) *</text>
<text top="656" left="466" width="51" height="7" font="font13" id="p1_t82" reading_order_no="97" segment_no="13" tag_type="table">0.50 (+/-0.5) **</text>
<text top="663" left="59" width="95" height="10" font="font11" id="p1_t83" reading_order_no="98" segment_no="13" tag_type="table">CD56 dim µ l/blood (+/-SD)</text>
<text top="666" left="283" width="54" height="7" font="font13" id="p1_t84" reading_order_no="99" segment_no="13" tag_type="table">179.3 (+/-135.3)</text>
<text top="666" left="372" width="48" height="7" font="font13" id="p1_t85" reading_order_no="100" segment_no="13" tag_type="table">174.8 (+/-135)</text>
<text top="666" left="466" width="52" height="7" font="font13" id="p1_t86" reading_order_no="101" segment_no="13" tag_type="table">197.7(+/-180.3)</text>
<text top="676" left="59" width="141" height="7" font="font11" id="p1_t87" reading_order_no="102" segment_no="13" tag_type="table">CD56 dim as % of lymphocytes (+/-SD)</text>
<text top="676" left="283" width="42" height="7" font="font13" id="p1_t88" reading_order_no="103" segment_no="13" tag_type="table">8.49 (+/-5.8)</text>
<text top="676" left="372" width="42" height="7" font="font13" id="p1_t89" reading_order_no="104" segment_no="13" tag_type="table">9.86 (+/-7.0)</text>
<text top="676" left="466" width="42" height="7" font="font13" id="p1_t90" reading_order_no="105" segment_no="13" tag_type="table">11.7 (+/-9.3)</text>
<text top="698" left="59" width="489" height="7" font="font13" id="p1_t91" reading_order_no="106" segment_no="14" tag_type="text">Statistical analysis was carried out as described in the Methods; * p = 0.031 between the 40–60 and 60+ age groups, ** p = 0.012 between the 20–</text>
<text top="708" left="59" width="443" height="7" font="font13" id="p1_t92" reading_order_no="107" segment_no="14" tag_type="text">40 and 60+ age groups. ***p = 0.03 between the 40–60 and 60+ age groups, ****p = 0.0004 between the 20–40 and 60+ age groups.</text>
<text top="87" left="55" width="168" height="7" font="font11" id="p1_t93" reading_order_no="2" segment_no="2" tag_type="title">Table 1: The effect of age on NK cell number</text>
<text top="105" left="59" width="33" height="7" font="font11" id="p1_t94" reading_order_no="3" segment_no="3" tag_type="table">Age(yrs)</text>
<text top="105" left="118" width="14" height="7" font="font11" id="p1_t95" reading_order_no="4" segment_no="3" tag_type="table">N =<a href="">21]</a> and</text>
<text top="102" left="151" width="118" height="10" font="font11" id="p1_t96" reading_order_no="5" segment_no="3" tag_type="table">Mean NK cell µ l/blood (+/- SD)</text>
<text top="105" left="329" width="154" height="7" font="font11" id="p1_t97" reading_order_no="6" segment_no="3" tag_type="table">Mean NK cells % of lymphocytes (+/-SD)</text>
<text top="127" left="59" width="22" height="7" font="font11" id="p1_t98" reading_order_no="7" segment_no="3" tag_type="table">20–40</text>
<text top="127" left="119" width="8" height="7" font="font13" id="p1_t99" reading_order_no="8" segment_no="3" tag_type="table">25<a href="">1]</a>. A substantial body of data indi-</text>
<text top="127" left="151" width="56" height="7" font="font13" id="p1_t100" reading_order_no="9" segment_no="3" tag_type="table">194.9 (+/- 140.4)</text>
<text top="127" left="329" width="44" height="7" font="font13" id="p1_t101" reading_order_no="10" segment_no="3" tag_type="table">9.25 (+/- 6.1)</text>
<text top="137" left="59" width="22" height="7" font="font11" id="p1_t102" reading_order_no="11" segment_no="3" tag_type="table">40–60</text>
<text top="137" left="119" width="8" height="7" font="font13" id="p1_t103" reading_order_no="12" segment_no="3" tag_type="table">23</text>
<text top="137" left="151" width="56" height="7" font="font13" id="p1_t104" reading_order_no="13" segment_no="3" tag_type="table">187.6 (+/- 144.5)</text>
<text top="137" left="329" width="48" height="7" font="font13" id="p1_t105" reading_order_no="14" segment_no="3" tag_type="table">10.59 (+/- 7.5)</text>
<text top="148" left="59" width="16" height="7" font="font11" id="p1_t106" reading_order_no="15" segment_no="3" tag_type="table">&gt; 60</text>
<text top="148" left="119" width="8" height="7" font="font13" id="p1_t107" reading_order_no="16" segment_no="3" tag_type="table">67</text>
<text top="148" left="151" width="56" height="7" font="font13" id="p1_t108" reading_order_no="17" segment_no="3" tag_type="table">205.8 (+/- 184.0)</text>
<text top="148" left="329" width="48" height="7" font="font13" id="p1_t109" reading_order_no="18" segment_no="3" tag_type="table">11.22 (+/- 9.1)<b>Table 2: The effect of age on CD56</b></text>
<text top="170" left="59" width="393" height="7" font="font13" id="p1_t110" reading_order_no="19" segment_no="4" tag_type="text">Statistical analysis was carried out as described in the Methods; no significant differences between groups were found.<b>bright </b></text>
</page>
</pdf2xml>
